Diabetes — all decisions

The Board granted service connection for tinnitus and denied service connection for diabetes mellitus, type II. The remaining claims for service connection were remanded.

The Board denied service connection for bilateral sensorineural hearing loss and remanded the claims for other conditions due to insufficient evidence.

The Board denied an earlier effective date for the grant of service connection for diabetes mellitus, type II, finding that March 16, 2022, is the appropriate effective date.

The Board granted an effective date of September 21, 2010, for the grant of service connection for obstructive sleep apnea (OSA) rated as 50 percent disabling but denied earlier effective dates for the grants of service connection for diabetes mellitus, type II, and traumatic brain injury.

The Board denied service connection for a thyroid condition, hypertension, skin cancer, and type II diabetes as the evidence did not support a finding of exposure to herbicides during service or a link between the conditions and service.

The Board denied earlier effective dates for the award of service connection for diabetes mellitus, type II, and PTSD, as well as an initial rating in excess of 70 percent for PTSD.

The appeal was dismissed due to an improper concurrent election of review types.

The Board granted service connection for type 2 diabetes mellitus, right and left upper and lower extremity idiopathic polyneuropathy, effective from April 20, 2015. The seizure disorder claim was remanded.

The Board denied service connection for a thyroid condition, hypertension, skin cancer, and type II diabetes as the evidence did not support a finding of exposure to herbicide agents during service or a link between the conditions and service.

The Board denied service connection for a thyroid condition, hypertension, skin cancer, and type II diabetes as the evidence did not support a finding of exposure to herbicide agents during service or a link between the conditions and service.

The Board denied service connection for a thyroid condition, hypertension, skin cancer, and type II diabetes as the evidence did not support a finding of exposure to herbicide agents during service or a link between the conditions and service.

The Board denied service connection for a thyroid condition, hypertension, skin cancer, and type II diabetes as the evidence did not support a finding of exposure to herbicide agents during service or a link between the conditions and service.

The Board denied service connection for a thyroid condition, hypertension, skin cancer, and type II diabetes as the evidence did not support a finding of exposure to herbicide agents during service or a link between the conditions and service.

The Board denied service connection for a thyroid condition, hypertension, skin cancer, and type II diabetes as the evidence did not support a finding of exposure to herbicide agents during service or a link between the conditions and service.

The Board denied service connection for a thyroid condition, hypertension, skin cancer, and type II diabetes as the evidence did not support a finding of exposure to herbicides during service or a link between the conditions and service.

The Board granted service connection for type II diabetes mellitus, hypertension under the PACT Act, and diabetic nephropathy. The claims for a heart condition, bilateral upper extremity diabetic neuropathy, and bilateral lower extremity diabetic neuropathy were also granted. The claim for erectile dysfunction was remanded.

The Board denied service connection for a thyroid condition, hypertension, skin cancer, and type II diabetes as the evidence did not support a finding of exposure to herbicide agents during service or a link between the conditions and service.

The Board dismissed the appeal for service connection for COPD and denied earlier effective dates on a presumptive basis for diabetes mellitus, but granted an earlier effective date for coronary artery disease. The Board also granted an increased rating from August 10, 2022 for diabetes mellitus.

The Board denied service connection for a thyroid condition, hypertension, skin cancer, and type II diabetes as the evidence did not support a finding of exposure to herbicide agents during service or a link between the conditions and service.

The Board denied an effective date prior to September 5, 2023, for a 100 percent rating for MDD and SMC based on housebound criteria. However, it granted service connection for right ear painful scar, right ear surgical scar, and sleep apnea with an effective date of November 30, 2020.